1-10 of 10
Claire L. Harris
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Response to Comment on “Functional Analysis of a Complement Polymorphism (rs17611) Associated with Rheumatoid Arthritis”

Joanna L. Giles, Ernest Choy, Carmen van den Berg, B. Paul Morgan, Claire L. Harris
Journal: The Journal of Immunology
J Immunol (2015) 195 (1): 4.
https://doi.org/10.4049/jimmunol.1500968
Published: 01 July 2015
View article titled, Response to Comment on “Functional Analysis of a Complement Polymorphism (rs17611) Associated with Rheumatoid Arthritis”
Open the PDF for Response to Comment on “Functional Analysis of a Complement Polymorphism (rs17611) Associated with Rheumatoid Arthritis” in another window
Add to Citation Manager
Journal Articles

Functional Analysis of a Complement Polymorphism (rs17611) Associated with Rheumatoid Arthritis

Joanna L. Giles, Ernest Choy, Carmen van den Berg, B. Paul Morgan, Claire L. Harris
Journal: The Journal of Immunology
J Immunol (2015) 194 (7): 3029–3034.
https://doi.org/10.4049/jimmunol.1402956
Published: 01 April 2015
View article titled, Functional Analysis of a Complement Polymorphism (rs17611) Associated with Rheumatoid Arthritis
Open the PDF for Functional Analysis of a Complement Polymorphism (rs17611) Associated with Rheumatoid Arthritis in another window
Add to Citation Manager
Includes: Supplementary data
Journal Articles

A Humanized Antibody That Regulates the Alternative Pathway Convertase: Potential for Therapy of Renal Disease Associated with Nephritic Factors

Danielle Paixão-Cavalcante, Eva Torreira, Margaret A. Lindorfer, Santiago Rodriguez de Cordoba, B. Paul Morgan, Ronald P. Taylor, Oscar Llorca, Claire L. Harris
Journal: The Journal of Immunology
J Immunol (2014) 192 (10): 4844–4851.
https://doi.org/10.4049/jimmunol.1303131
Published: 15 May 2014
View article titled, A Humanized Antibody That Regulates the Alternative Pathway Convertase: Potential for Therapy of Renal Disease Associated with Nephritic Factors
Open the PDF for A Humanized Antibody That Regulates the Alternative Pathway Convertase: Potential for Therapy of Renal Disease Associated with Nephritic Factors in another window
Add to Citation Manager
Includes: Supplementary data
Journal Articles

Zymosan, but Not Lipopolysaccharide, Triggers Severe and Progressive Peritoneal Injury Accompanied by Complement Activation in a Rat Peritonitis Model

Masashi Mizuno, Yasuhiko Ito, Natalie Hepburn, Tomohiro Mizuno, Yukihiro Noda, Yukio Yuzawa, Claire L. Harris, B. Paul Morgan, Seiichi Matsuo
Journal: The Journal of Immunology
J Immunol (2009) 183 (2): 1403–1412.
https://doi.org/10.4049/jimmunol.0804245
Published: 15 July 2009
View article titled, Zymosan, but Not Lipopolysaccharide, Triggers Severe and Progressive Peritoneal Injury Accompanied by Complement Activation in a Rat Peritonitis Model
Open the PDF for Zymosan, but Not Lipopolysaccharide, Triggers Severe and Progressive Peritoneal Injury Accompanied by Complement Activation in a Rat Peritonitis Model in another window
Add to Citation Manager
Journal Articles

CD59, a Complement Regulatory Protein, Controls Choroidal Neovascularization in a Mouse Model of Wet-Type Age-Related Macular Degeneration

Nalini S. Bora, Sankaranarayanan Kaliappan, Purushottam Jha, Qin Xu, Baalasubramanian Sivasankar, Claire L. Harris, B. Paul Morgan, Puran S. Bora
Journal: The Journal of Immunology
J Immunol (2007) 178 (3): 1783–1790.
https://doi.org/10.4049/jimmunol.178.3.1783
Published: 01 February 2007
View article titled, CD59, a Complement Regulatory Protein, Controls Choroidal Neovascularization in a Mouse Model of Wet-Type Age-Related Macular Degeneration
Open the PDF for CD59, a Complement Regulatory Protein, Controls Choroidal Neovascularization in a Mouse Model of Wet-Type Age-Related Macular Degeneration in another window
Add to Citation Manager
Journal Articles

Decay-Accelerating Factor Must Bind Both Components of the Complement Alternative Pathway C3 Convertase to Mediate Efficient Decay

Claire L. Harris, David M. Pettigrew, Susan M. Lea, B. Paul Morgan
Journal: The Journal of Immunology
J Immunol (2007) 178 (1): 352–359.
https://doi.org/10.4049/jimmunol.178.1.352
Published: 01 January 2007
View article titled, Decay-Accelerating Factor Must Bind Both Components of the Complement Alternative Pathway C3 Convertase to Mediate Efficient Decay
Open the PDF for Decay-Accelerating Factor Must Bind Both Components of the Complement Alternative Pathway C3 Convertase to Mediate Efficient Decay in another window
Add to Citation Manager
Journal Articles

Increased Susceptibility to Complement Attack due to Down-Regulation of Decay-Accelerating Factor/CD55 in Dysferlin-Deficient Muscular Dystrophy

Katrin Wenzel, Joanna Zabojszcza, Miriam Carl, Semjon Taubert, Antje Lass, Claire L. Harris, Mengfatt Ho, Herbert Schulz, Oliver Hummel, Norbert Hubner, Karl Josef Osterziel, Simone Spuler
Journal: The Journal of Immunology
J Immunol (2005) 175 (9): 6219–6225.
https://doi.org/10.4049/jimmunol.175.9.6219
Published: 01 November 2005
View article titled, Increased Susceptibility to Complement Attack due to Down-Regulation of Decay-Accelerating Factor/CD55 in Dysferlin-Deficient Muscular Dystrophy
Open the PDF for Increased Susceptibility to Complement Attack due to Down-Regulation of Decay-Accelerating Factor/CD55 in Dysferlin-Deficient Muscular Dystrophy in another window
Add to Citation Manager
Includes: Supplementary data
Journal Articles

Decay-Accelerating Factor (CD55) Is Expressed by Neurons in Response to Chronic but Not Acute Autoimmune Central Nervous System Inflammation Associated with Complement Activation

Johan van Beek, Marjan van Meurs, Bert A. ‘t Hart, Herbert P. M. Brok, Jim W. Neal, Alexandra Chatagner, Claire L. Harris, Nader Omidvar, B. Paul Morgan, Jon D. Laman, Philippe Gasque
Journal: The Journal of Immunology
J Immunol (2005) 174 (4): 2353–2365.
https://doi.org/10.4049/jimmunol.174.4.2353
Published: 15 February 2005
View article titled, Decay-Accelerating Factor (CD55) Is Expressed by Neurons in Response to Chronic but Not Acute Autoimmune Central Nervous System Inflammation Associated with Complement Activation
Open the PDF for Decay-Accelerating Factor (CD55) Is Expressed by Neurons in Response to Chronic but Not Acute Autoimmune Central Nervous System Inflammation Associated with Complement Activation in another window
Add to Citation Manager
Journal Articles

CD59a Is the Primary Regulator of Membrane Attack Complex Assembly in the Mouse

Sivasankar Baalasubramanian, Claire L. Harris, Rossen M. Donev, Masashi Mizuno, Nader Omidvar, Wen-Chao Song, B. Paul Morgan
Journal: The Journal of Immunology
J Immunol (2004) 173 (6): 3684–3692.
https://doi.org/10.4049/jimmunol.173.6.3684
Published: 15 September 2004
View article titled, CD59a Is the Primary Regulator of Membrane Attack Complex Assembly in the Mouse
Open the PDF for CD59a Is the Primary Regulator of Membrane Attack Complex Assembly in the Mouse in another window
Add to Citation Manager
Journal Articles

A Bispecific Monoclonal Antibody Directed Against Both the Membrane-Bound Complement Regulator CD55 and the Renal Tumor-Associated Antigen G250 Enhances C3 Deposition and Tumor Cell Lysis by Complement

Vanessa T. Blok, Mohamed R. Daha, Odette Tijsma, Claire L. Harris, B. Paul Morgan, Gert Jan Fleuren, Arko Gorter
Journal: The Journal of Immunology
J Immunol (1998) 160 (7): 3437–3443.
https://doi.org/10.4049/jimmunol.160.7.3437
Published: 01 April 1998
View article titled, A Bispecific Monoclonal Antibody Directed Against Both the Membrane-Bound Complement Regulator CD55 and the Renal Tumor-Associated Antigen G250 Enhances C3 Deposition and Tumor Cell Lysis by Complement
Open the PDF for A Bispecific Monoclonal Antibody Directed Against Both the Membrane-Bound Complement Regulator CD55 and the Renal Tumor-Associated Antigen G250 Enhances C3 Deposition and Tumor Cell Lysis by Complement in another window
Add to Citation Manager